M

Merck

Makes medicines, vaccines and animal treatments

General Technician - HEPA Technician

Full-TimeDeadline 10/23/26
No salary listed
Mid, Senior
West Point, PA, USA
In Person
Building TradesHVAC & Building Systems
No H1B Sponsorship

About the job

Requirements
  • A high school diploma or equivalent (GED) is required.
  • Graduation from a recognized or accredited HVAC/Refrigeration trade school, community college, or equivalent program with at least six months full-time emphasis (650 hours) in air conditioning, refrigeration, electricity, and associated controls, plus at least two years of recent full-time HEPA certification technician experience performing leak testing and velocity testing; alternatively, completion of a HEPA certification training program and one year of experience.
  • Alternatively, completion of a formal Air Conditioning and Refrigeration Mechanic Apprentice Program approved by the United States Department of Labor or an equivalent program.
  • Alternatively, verified military training equivalent to a recognized or accredited trade school or journeyman apprenticeship program, plus either at least two years of recent full-time HEPA certification technician experience performing leak testing and velocity testing, or completion of a HEPA certification training program and one year of experience.
  • Alternatively, no formal education is required if the candidate has completed a HEPA certification training program and has at least five years of recent full-time HEPA certification technician experience performing leak testing and velocity testing.
  • Ability to read HVAC drawings.
  • Mechanical aptitude.
  • Must take immunizations as prescribed by the company’s Health Services Department.
  • Must wear a company-issued uniform in accordance with company standard operating procedures.
  • The position is subject to a probationary period.
  • Must be available during the work shift to respond to emergencies and may be required to carry a pager and/or radio.
  • The work involves heavy lifting, aseptic gowning, heat and cold, dust and dirt, safety shoes and glasses, confined spaces, roofs and heights, and possible work around potentially infectious agents.
Responsibilities
  • Install, maintain, test, certify, repair, and troubleshoot HEPA filtration equipment in compliance with operating procedures, company and government regulations, and current Good Manufacturing Practices.
  • Perform maintenance on equipment or facilities supported by the technician’s skills, including work in classified facilities requiring aseptic gowning, satisfactory titers, and RODAC testing.
  • Perform and document HEPA certifications of Unidirectional Airflow Rooms and Hoods, Class I and Class II Biosafety Cabinets, Air Handler Units, and miscellaneous HEPA-filtered equipment.
  • Perform leak checks, velocity spot checks, non-viable particle counts, airflow pattern tests, and other tests as required by procedure; work from ladders and above head height for six or more hours per day as needed.
  • Verify equipment numbers and work-order associations before conducting HEPA-certification tasks.
  • Affix certification tags or Equipment Defective Notice tags to equipment according to procedure.
  • Manage and maintain equipment used for HEPA certifications and velocity spot checks.
  • Perform Enterprise Asset Management transactions as needed and use electronic data collection technology.
  • Perform corrective maintenance to repair, replace, or adjust equipment proactively or following certification failures, including structural filter repairs and HEPA filter replacements.
  • Assist Utilities technicians with troubleshooting and adjusting HVAC systems to maintain proper airflow conditions.
  • Monitor and measure HVAC filter pressure drop and replace filters as necessary while observing system-integrity and safety requirements.
  • Carry a radio as directed to communicate problems promptly.
  • Use work orders and preventive-maintenance checklists, maintain work records and logs in a current Good Manufacturing Practices-compliant manner, and document activities through daily labor records and other GMP systems as needed.
  • Communicate with supervisors and customers about equipment and system status, parts, and other work requirements.
  • Complete department training as directed, including orientation, standard operating procedures, and safety training.
  • Attend and actively participate in HAZOPS, waste walkthroughs, Kaizen events, and required operations, lean six sigma, quality, safety, or environmental initiatives.
  • Prepare and assist technicians, supervisors, and planners with labor and material estimates.
  • Assist supervision with assigning, scheduling, and prioritizing work-order requests using maintenance management systems.
  • Recommend and prepare orders for spare parts, additional stockroom items, tools, and related supplies.
  • Consult with supervisors and other mechanics to resolve and troubleshoot problems, and keep supervisors informed of issues.
  • Write, execute, and complete safety permits.
Desired Qualifications
  • Demonstrate an understanding of testing, adjusting, and balancing HVAC systems.

About the company

Merck develops prescription medicines, vaccines and veterinary treatments for patients, health systems and animal owners worldwide. Its vaccine portfolio includes Gardasil 9, which helps prevent cancers and other diseases caused by several types of human papillomavirus. The company takes potential treatments through laboratory research and clinical trials, then manufactures and sells approved products to drug distributors, hospitals, physicians and governments. Its animal health division sells medicines and vaccines to veterinarians, farmers and pet owners, while selected drug partnerships also earn shared profits or royalties. Founded in 1891, Merck is headquartered in Rahway, New Jersey.

Company Size

10,001+

Company Stage

IPO

Headquarters

Rahway, New Jersey

Founded

1891

Get referred to Merck

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • U.S. employees build retirement benefits: Merck pairs a defined benefit pension with a matching 401(k).
  • Scientists work within a large research network: Merck reports approximately 24,700 employees in R&D.
  • Animal health adds growth: August 2026 results report Q2 sales of $1.8 billion, up 8% year over year.

What critics are saying

  • Job security faces cuts: Merck's active restructuring program eliminates roles and shrinks its global real estate footprint.
  • Keytruda protection narrows: its main U.S. patent expires in 2028, with additional patents expiring in 2029.
  • Revenue is concentrated: August 2026 results show Keytruda products generated $8.4 billion of Merck's $16.6 billion Q2 sales.

What makes Merck unique

  • Merck extends into farm technology: SenseHub continuously monitors livestock for behavioral and physiological changes.
  • Merck publishes open medical knowledge: its Manuals give clinicians and patients free online references.
  • Merck's donation commitment is open-ended: Mectizan supplies for river blindness continue for as long as needed.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Paid Vacation
  • Paid Sick Leave
  • Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

-19%

1 year growth

-20%

2 year growth

-20%
Yahoo Finance
Oct 21st, 2026
Keytruda is half of Merck's $16.6B quarterly sales, so what if growth stalls?

Merck's Keytruda cancer drug family generated $8.4 billion in fiscal Q2 2026, about half of the company's $16.6 billion revenue. Excluding currency, Keytruda sales grew 4%, the same pace as total revenue. Management said on the August 4 call that US Keytruda growth will moderate as the drug reaches peak penetration. A Dutch court has also barred Merck from selling subcutaneous Keytruda in eight European markets, Barron's reported. Newer drugs are growing faster. WINREVAIR sales rose 75% to $588 million, and WELIREG sales rose 67%. Free cash flow of $16.1 billion covered dividends of $8.3 billion about twice. Total debt rose to $53.9 billion from $35.4 billion a year earlier. Merck is expected to report results on October 29.

Ash
Oct 20th, 2026
Ash announces $10M Series A funding to uplevel at-home health testing to close healthcare gaps for millions

Ash secures $10M Series A funding led by Merck GHI Fund. We are scaling at home lab test programs to close care gaps and bring patients into the care cycle.

Yahoo Finance
Oct 19th, 2026
Merck and AbbVie shares jump 39% and 24% in 2026 as dividend picks for a decade

Healthcare stocks are rebounding in 2026, led by Merck and AbbVie. Merck shares have climbed 39% and AbbVie's 24%, against about 12% for the S&P 500. Merck's second-quarter revenue rose 5% to $16.6 billion, beating Wall Street estimates. Keytruda sales hit $8.4 billion, though the drug will likely lose patent exclusivity by 2028. A subcutaneous version, Keytruda Qlex, may help retain market share. Merck's forward dividend yield is 2.3%. AbbVie's revenue grew 10.2% to almost $17 billion, with adjusted earnings per share up 22.9% to $3.65. Skyrizi and Rinvoq sales each rose about 24%, and neither faces US competition until 2033 and 2037 respectively. AbbVie has raised its dividend for 54 straight years, including its time as part of Abbott Laboratories.

WebBizMarket
Oct 19th, 2026
Cancer vaccine manufacturing time could shrink.

Cancer vaccine manufacturing time could shrink. Merck's CEO Rob Davis expressed optimism regarding the manufacturing timeline of the company's cancer vaccine developed in collaboration with Moderna. In a recent interview with CNBC, Davis indicated that efforts are being made to shorten the current six-week production period, which could improve patient access to this innovative treatment. The vaccine is personalized, targeting mutations specific to each patient's tumor, which complicates production but is designed to enhance the immune system's ability to combat cancer. Davis emphasized the complexity of the vaccine manufacturing process but conveyed confidence in the collaboration between Merck and Moderna, stating that they have refined the process to ensure timely delivery to patients. Positive preliminary data from a late-stage trial involving melanoma patients has bolstered this optimism, with ongoing investigations into the vaccine's efficacy against other cancers, including non-small cell lung cancer and bladder cancer. In a related development, Merck has inaugurated a new 120,000-square-foot research facility named Advance at its West Point, Pennsylvania campus. This facility incorporates advanced technology aimed at enhancing research and development processes. The launch comes as Merck anticipates the expiration of patents for its flagship drug, Keytruda, which is essential to its revenue model. To mitigate potential revenue loss, the company plans to bolster its pipeline with both internal research and substantial external acquisitions. Merck is also addressing legal challenges regarding the subcutaneous formulation of Keytruda in Europe, where a recent court ruling has affected its market capabilities. Despite these hurdles, the company remains focused on introducing new therapies, including its recently approved cholesterol-lowering medication, Lipfendra. Why this story matters * This vaccine represents a significant advancement in personalized cancer treatment, potentially improving patient outcomes. Key takeaway * Merck and Moderna are committed to refining the manufacturing process of their personalized cancer vaccine, aiming for broader patient access. Opposing viewpoint * Legal challenges regarding Keytruda's subcutaneous formulation could hinder market penetration and affect future revenues.

Spot On Pennsylvania
Oct 16th, 2026
Merck expands near philadelphia as riverside plant winds down.

Merck expands near philadelphia as riverside plant winds down. RIVERSIDE - While Merck is closing its longtime manufacturing operation in Northumberland County, the pharmaceutical company is preparing a major expansion elsewhere in Pennsylvani... Discover more Get Sports Gear Discover more Read Daily News